BitMine increases ethereum holdings to $6.6 billion, adds 373,000 tokens
Investing.com - Neuronetics reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Neuronetics announced earnings per share of $-0.28 on revenue of $16.5M. Analysts polled by Investing.com EPS of $-0.43 on revenue of $15.02M.
Neuronetics 's are down 20% and is trading at $4.26 , still down 37.39% from its 52 week high of $5.91 set on Tuesday, November 9, 2021.
Neuronetics shares gained 15.14% to trade at $4.26 in pre-market trade the report.
Neuronetics follows other major Healthcare sector earnings this month
Neuronetics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar